Adelaide Research & Scholarship: Search

Search

Results 31-40 of 47 (Search time: 0.002 seconds).

previous
1
2
3
4
5
next

Item hits:

Preview	Issue Date	Title	Author(s)
	1999	Assessment of interlaboratory performance in the provision of perhexiline therapeutic drug monitoring services in Australia.	Sallustio, B.; Morris, R.
	1999	Some international approaches to aminoglycoside monitoring in the extended dosing interval era	Morris, R.; Sallustio, B.; Vinks, A.; LeGatt, D.; Verjee, Z.; Desoky, E.
	2004	Concentration-time profile for perhexiline and hydroxyperhexiline in patients at steady state	Jones, T.; Morris, R.; Horowitz, J.
	2004	Development of a regimen for rapid initiation of perhexiline therapy in acute coronary syndromes	Philpott, A.; Chandy, S.; Morris, R.; Horowitz, J.
	2006	Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range	Morris, R.; Jones, T.; Goldsworthy, S.; Wagner, T.; Ho, H.; Horowitz, J.
	2006	A Bayesian approach for population pharmacokinetic modelling of sirolimus	Dansirikul, C.; Morris, R.; Tett, S.; Duffull, S.
	2005	Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipients	Dansirikul, C.; Duffull, S.; Morris, R.; Tett, S.
	2004	Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexiline	Davies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
	2007	Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia	Inglis, S.; Herbert, M.; Davies, B.; Coller, J.; James, H.; Horowitz, J.; Morris, R.; Milne, R.; Somogyi, A.; Sallustio, B.
	2011	Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods	Sallustio, B.; Noll, B.; Morris, R.